{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:47:55Z","timestamp":1793299675827,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1038\/s41401-020-0490-7","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T08:02:59Z","timestamp":1596787379000},"page":"230-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":207,"title":["Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation"],"prefix":"10.1038","volume":"42","author":[{"given":"Shu","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-liang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-ru","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-liang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"key":"490_CR1","doi-asserted-by":"crossref","first-page":"E3299","DOI":"10.3390\/ijms20133299","volume":"20","author":"T Filardi","year":"2019","unstructured":"Filardi T, Ghinassi B, Di Baldassarre A, Tanzilli G, Morano S, Lenzi A, et al. Cardiomyopathy associated with diabetes: the central role of the cardiomyocyte. Int J Mol Sci. 2019;20:E3299.","journal-title":"Int J Mol Sci"},{"key":"490_CR2","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.biopha.2018.11.086","volume":"109","author":"AM Al Hroob","year":"2019","unstructured":"Al Hroob AM, Abukhalil MH, Hussein OE, Mahmoud AM. Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate. Biomed Pharmacother. 2019;109:2155\u201372.","journal-title":"Biomed Pharmacother"},{"key":"490_CR3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/5584_2017_105","volume":"1067","author":"N Alonso","year":"2018","unstructured":"Alonso N, Moliner P, Mauricio D. Pathogenesis, clinical features and treatment of diabetic cardiomyopathy. Adv Exp Med Biol. 2018;1067:197\u2013217.","journal-title":"Adv Exp Med Biol"},{"key":"490_CR4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3389\/fphar.2018.00955","volume":"9","author":"X Wei","year":"2018","unstructured":"Wei X, Tao J, Shen Y, Xiao S, Jiang S, Shang E, et al. Sanhuang Xiexin Tang ameliorates type 2 diabetic rats via modulation of the metabolic profiles and NF-kappaB\/PI3K\/Akt signaling pathways. Front Pharmacol. 2018;9:955.","journal-title":"Front Pharmacol"},{"key":"490_CR5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/0929867321666140912155738","volume":"22","author":"H Cao","year":"2015","unstructured":"Cao H, Chen T, Shi Y. Glycation of human serum albumin in diabetes: impacts on the structure and function. Curr Med Chem. 2015;22:4\u201313.","journal-title":"Curr Med Chem"},{"key":"490_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","volume":"61","author":"G Jia","year":"2018","unstructured":"Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61:21\u20138.","journal-title":"Diabetologia"},{"key":"490_CR7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4239\/wjd.v10.i10.490","volume":"10","author":"L Athithan","year":"2019","unstructured":"Athithan L, Gulsin GS, McCann GP, Levelt E. Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date. World J Diabetes. 2019;10:490\u2013510.","journal-title":"World J Diabetes"},{"key":"490_CR8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.hfc.2019.02.003","volume":"15","author":"S Paolillo","year":"2019","unstructured":"Paolillo S, Marsico F, Prastaro M, Renga F, Esposito L, De Martino F, et al. Diabetic cardiomyopathy: definition, diagnosis, and therapeutic implications. Heart Fail Clin. 2019;15:341\u20137.","journal-title":"Heart Fail Clin"},{"key":"490_CR9","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/bph.13861","volume":"175","author":"G Meng","year":"2018","unstructured":"Meng G, Liu J, Liu S, Song Q, Liu L, Xie L, et al. Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner. Br J Pharmacol. 2018;175:1126\u201345.","journal-title":"Br J Pharmacol"},{"key":"490_CR10","doi-asserted-by":"crossref","first-page":"9396089","DOI":"10.1155\/2018\/9396089","volume":"2018","author":"J Zhang","year":"2018","unstructured":"Zhang J, Yu J, Chen Y, Liu L, Xu M, Sun L, et al. Exogenous hydrogen sulfide supplement attenuates isoproterenol-induced myocardial hypertrophy in a sirtuin 3-dependent manner. Oxid Med Cell Longev. 2018;2018:9396089.","journal-title":"Oxid Med Cell Longev"},{"key":"490_CR11","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/bph.13825","volume":"175","author":"G Meng","year":"2018","unstructured":"Meng G, Zhao S, Xie L, Han Y, Ji Y. Protein S-sulfhydration by hydrogen sulfide in cardiovascular system. Br J Pharmacol. 2018;175:1146\u201356.","journal-title":"Br J Pharmacol"},{"key":"490_CR12","doi-asserted-by":"crossref","first-page":"7293861","DOI":"10.1155\/2018\/7293861","volume":"2018","author":"W Sun","year":"2018","unstructured":"Sun W, Liu C, Chen Q, Liu N, Yan Y, Liu B. SIRT3: a new regulator of cardiovascular diseases. Oxid Med Cell Longev. 2018;2018:7293861.","journal-title":"Oxid Med Cell Longev"},{"key":"490_CR13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/CIRCRESAHA.120.316567","volume":"126","author":"FJ Miller Jr","year":"2020","unstructured":"Miller FJ Jr. Hypertension and mitochondrial oxidative stress revisited: sirtuin 3, the improved \u201cantioxidant\u201d. Circ Res. 2020;126:453\u20135.","journal-title":"Circ Res"},{"key":"490_CR14","doi-asserted-by":"crossref","first-page":"e22249","DOI":"10.1002\/jbt.22249","volume":"33","author":"X Li","year":"2019","unstructured":"Li X, Song S, Xu M, Hua Y, Ding Y, Shan X, et al. Sirtuin3 deficiency exacerbates carbon tetrachloride-induced hepatic injury in mice. J Biochem Mol Toxicol. 2019;33:e22249.","journal-title":"J Biochem Mol Toxicol"},{"key":"490_CR15","first-page":"863","volume":"21","author":"C Zhu","year":"2018","unstructured":"Zhu C, Liu Y, Guan Z, Zhou Y, Liu F, Zhang T. Hypoxia-reoxygenation induced necroptosis in cultured rat renal tubular epithelial cell line. Iran J Basic Med Sci. 2018;21:863\u20138.","journal-title":"Iran J Basic Med Sci"},{"key":"490_CR16","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/jcp.27200","volume":"234","author":"X He","year":"2019","unstructured":"He X, Zeng H, Chen JX. Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular disease. J Cell Physiol. 2019;234:2252\u201365.","journal-title":"J Cell Physiol"},{"key":"490_CR17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10715762.2018.1549732","volume":"53","author":"J Wu","year":"2019","unstructured":"Wu J, Zeng Z, Zhang W, Deng Z, Wan Y, Zhang Y, et al. Emerging role of SIRT3 in mitochondrial dysfunction and cardiovascular diseases. Free Radic Res. 2019;53:139\u201349.","journal-title":"Free Radic Res"},{"key":"490_CR18","doi-asserted-by":"crossref","first-page":"113621","DOI":"10.1016\/j.bcp.2019.08.023","volume":"169","author":"J Storder","year":"2019","unstructured":"Storder J, Renard P, Arnould T. Update on the role of sirtuin 3 in cell differentiation: a major metabolic target that can be pharmacologically controlled. Biochem Pharmacol. 2019;169:113621.","journal-title":"Biochem Pharmacol"},{"key":"490_CR19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fphar.2020.00042","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen Y, Hua Y, Li X, Arslan IM, Zhang W, Meng G. Distinct types of cell death and the implication in diabetic cardiomyopathy. Front Pharmacol. 2020;11:42.","journal-title":"Front Pharmacol"},{"key":"490_CR20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ajpath.2019.10.012","volume":"190","author":"MK Khoury","year":"2020","unstructured":"Khoury MK, Gupta K, Franco SR, Liu B. Necroptosis in the pathophysiology of disease. Am J Pathol. 2020;190:272\u201385.","journal-title":"Am J Pathol"},{"key":"490_CR21","doi-asserted-by":"publisher","unstructured":"Dhuriya YK, Sharma D. Necroptosis: a regulated inflammatory mode of cell death. J Neuroinflammation. 2018;15:199.\u00a0https:\/\/doi.org\/10.1186\/s12974-018-1235-0.","DOI":"10.1186\/s12974-018-1235-0"},{"key":"490_CR22","doi-asserted-by":"crossref","first-page":"eaax8295","DOI":"10.1126\/scisignal.aax8295","volume":"13","author":"S Jensen","year":"2020","unstructured":"Jensen S, Seidelin JB, LaCasse EC, Nielsen OH. SMAC mimetics and RIPK inhibitors as therapeutics for chronic inflammatory diseases. Sci Signal. 2020;13:eaax8295.","journal-title":"Sci Signal"},{"key":"490_CR23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tips.2020.01.002","volume":"41","author":"S Martens","year":"2020","unstructured":"Martens S, Hofmans S, Declercq W, Augustyns K, Vandenabeele P. Inhibitors targeting RIPK1\/RIPK3: old and new drugs. Trends Pharmacol Sci. 2020;41:209\u201324.","journal-title":"Trends Pharmacol Sci"},{"key":"490_CR24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2018.03.003","volume":"118","author":"K Gupta","year":"2018","unstructured":"Gupta K, Phan N, Wang Q, Liu B. Necroptosis in cardiovascular disease\u2014a new therapeutic target. J Mol Cell Cardiol. 2018;118:26\u201335.","journal-title":"J Mol Cell Cardiol"},{"key":"490_CR25","doi-asserted-by":"crossref","first-page":"e1600224","DOI":"10.1126\/sciadv.1600224","volume":"2","author":"D Karunakaran","year":"2016","unstructured":"Karunakaran D, Geoffrion M, Wei L, Gan W, Richards L, Shangari P, et al. Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis. Sci Adv. 2016;2:e1600224.","journal-title":"Sci Adv"},{"key":"490_CR26","doi-asserted-by":"crossref","first-page":"128834","DOI":"10.1172\/jci.insight.128834","volume":"4","author":"ME Choi","year":"2019","unstructured":"Choi ME, Price DR, Ryter SW, Choi AMK. Necroptosis: a crucial pathogenic mediator of human disease. JCI Insight. 2019;4:128834.","journal-title":"JCI Insight"},{"key":"490_CR27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.toxlet.2018.10.020","volume":"301","author":"L Du","year":"2019","unstructured":"Du L, Shen K, Bai Y, Chao J, Hu G, Zhang Y, et al. Involvement of NLRP3 inflammasome in methamphetamine-induced microglial activation through miR-143\/PUMA axis. Toxicol Lett. 2019;301:53\u201363.","journal-title":"Toxicol Lett"},{"key":"490_CR28","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.molcel.2017.02.024","volume":"65","author":"CJ Kearney","year":"2017","unstructured":"Kearney CJ, Martin SJ. An inflammatory perspective on necroptosis. Mol Cell. 2017;65:965\u201373.","journal-title":"Mol Cell"},{"key":"490_CR29","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/labinvest.2017.30","volume":"97","author":"R Wang","year":"2017","unstructured":"Wang R, Wang Y, Mu N, Lou X, Li W, Chen Y, et al. Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice. Lab Investig. 2017;97:922\u201334.","journal-title":"Lab Investig"},{"key":"490_CR30","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1111\/jcmm.15100","volume":"24","author":"S Yang","year":"2020","unstructured":"Yang S, Xu M, Meng G, Lu Y. SIRT3 deficiency delays diabetic skin wound healing via oxidative stress and necroptosis enhancement. J Cell Mol Med. 2020;24:4415\u201327.","journal-title":"J Cell Mol Med"},{"key":"490_CR31","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.2337\/db16-0020","volume":"65","author":"L Xie","year":"2016","unstructured":"Xie L, Gu Y, Wen M, Zhao S, Wang W, Ma Y, et al. Hydrogen sulfide induces Keap1 S-sulfhydration and suppresses diabetes-accelerated atherosclerosis via Nrf2 activation. Diabetes. 2016;65:3171\u201384.","journal-title":"Diabetes"},{"key":"490_CR32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4939-6747-6_14","volume":"1550","author":"L Zhang","year":"2017","unstructured":"Zhang L, Elias JE. Relative protein quantification using tandem mass tag mass spectrometry. Methods Mol Biol. 2017;1550:185\u201398.","journal-title":"Methods Mol Biol"},{"key":"490_CR33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bcp.2019.02.022","volume":"163","author":"L Sun","year":"2019","unstructured":"Sun L, Chen Y, Luo H, Xu M, Meng G, Zhang W. Ca2+\/calmodulin-dependent protein kinase II regulation by inhibitor 1 of protein phosphatase 1 alleviates necroptosis in high glucose-induced cardiomyocytes injury. Biochem Pharmacol. 2019;163:194\u2013205.","journal-title":"Biochem Pharmacol"},{"key":"490_CR34","first-page":"2193019","volume":"2019","author":"H Luo","year":"2019","unstructured":"Luo H, Song S, Chen Y, Xu M, Sun L, Meng G, et al. Inhibitor 1 of protein phosphatase 1 regulates Ca2+\/Calmodulin-dependent protein kinase II to alleviate oxidative stress in hypoxia-reoxygenation injury of cardiomyocytes. Oxid Med Cell Longev. 2019;2019:2193019.","journal-title":"Oxid Med Cell Longev"},{"key":"490_CR35","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.3390\/genes11020131","volume":"11","author":"RH Pirzada","year":"2020","unstructured":"Pirzada RH, Javaid N, Choi S. The roles of the NLRP3 inflammasome in neurodegenerative and metabolic diseases and in relevant advanced therapeutic interventions. Genes. 2020;11:E131.","journal-title":"Genes"},{"key":"490_CR36","doi-asserted-by":"crossref","first-page":"E736","DOI":"10.3390\/cells9030736","volume":"9","author":"L Maroni","year":"2020","unstructured":"Maroni L, Ninfole E, Pinto C, Benedetti A, Marzioni M. Gut-liver axis and inflammasome activation in cholangiocyte pathophysiology. Cells. 2020;9:E736.","journal-title":"Cells"},{"key":"490_CR37","first-page":"4063562","volume":"2020","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zhang S, Xiao Y, Zhang W, Wu S, Qin T, et al. NLRP3 inflammasome and inflammatory diseases. Oxid Med Cell Longev. 2020;2020:4063562.","journal-title":"Oxid Med Cell Longev"},{"key":"490_CR38","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122:624\u201338.","journal-title":"Circ Res"},{"key":"490_CR39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/1573399815666190411115829","volume":"16","author":"MA Baig","year":"2019","unstructured":"Baig MA, Panchal SS. Streptozotocin-induced diabetes mellitus in neonatal rats: an insight into its applications to induce diabetic complications. Curr Diabetes Rev. 2019;16:26\u201339.","journal-title":"Curr Diabetes Rev"},{"key":"490_CR40","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ccell.2019.05.002","volume":"35","author":"M Li","year":"2019","unstructured":"Li M, Chiang YL, Lyssiotis CA, Teater MR, Hong JY, Shen H, et al. Non-oncogene addiction to SIRT3 plays a critical role in lymphomagenesis. Cancer Cell. 2019;35:916\u201331.","journal-title":"Cancer Cell"},{"key":"490_CR41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.molmet.2019.04.008","volume":"25","author":"R Sebaa","year":"2019","unstructured":"Sebaa R, Johnson J, Pileggi C, Norgren M, Xuan J, Sai Y, et al. SIRT3 controls brown fat thermogenesis by deacetylation regulation of pathways upstream of UCP1. Mol Metab. 2019;25:35\u201349.","journal-title":"Mol Metab"},{"key":"490_CR42","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/ars.2018.7703","volume":"31","author":"A Benigni","year":"2019","unstructured":"Benigni A, Cassis P, Conti S, Perico L, Corna D, Cerullo D, et al. Sirt3 deficiency shortens life span and impairs cardiac mitochondrial function rescued by Opa1 gene transfer. Antioxid Redox Signal. 2019;31:1255\u201371.","journal-title":"Antioxid Redox Signal"},{"key":"490_CR43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijcard.2016.04.092","volume":"215","author":"X He","year":"2016","unstructured":"He X, Zeng H, Chen JX. Ablation of SIRT3 causes coronary microvascular dysfunction and impairs cardiac recovery post myocardial ischemia. Int J Cardiol. 2016;215:349\u201357.","journal-title":"Int J Cardiol"},{"key":"490_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2018.09.009","volume":"53","author":"J Liu","year":"2019","unstructured":"Liu J, Yan W, Zhao X, Jia Q, Wang J, Zhang H, et al. Sirt3 attenuates post-infarction cardiac injury via inhibiting mitochondrial fission and normalization of AMPK-Drp1 pathways. Cell Signal. 2019;53:1\u201313.","journal-title":"Cell Signal"},{"key":"490_CR45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","volume":"20","author":"J Yuan","year":"2019","unstructured":"Yuan J, Amin P, Ofengeim D. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci. 2019;20:19\u201333.","journal-title":"Nat Rev Neurosci"},{"key":"490_CR46","first-page":"771","volume":"44","author":"Y Liu","year":"2019","unstructured":"Liu Y, Liu T, Lei T, Zhang D, Du S, Girani L, et al. RIP1\/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review). Int J Mol Med. 2019;44:771\u201386.","journal-title":"Int J Mol Med"},{"key":"490_CR47","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3389\/fphar.2018.00721","volume":"9","author":"S Zhe-Wei","year":"2018","unstructured":"Zhe-Wei S, Li-Sha G, Yue-Chun L. The role of necroptosis in cardiovascular disease. Front Pharmacol. 2018;9:721.","journal-title":"Front Pharmacol"},{"key":"490_CR48","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Su SS, Zhao S, Yang Z, Zhong CQ, Chen X, et al. RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat Commun. 2017;8:14329.","journal-title":"Nat Commun"},{"key":"490_CR49","doi-asserted-by":"crossref","first-page":"eaaw2004","DOI":"10.1126\/sciimmunol.aaw2004","volume":"4","author":"AG Snyder","year":"2019","unstructured":"Snyder AG, Hubbard NW, Messmer MN, Kofman SB, Hagan CE, Orozco SL, et al. Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity. Sci Immunol. 2019;4:eaaw2004.","journal-title":"Sci Immunol"},{"key":"490_CR50","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41586-020-2129-8","volume":"580","author":"H Jiao","year":"2020","unstructured":"Jiao H, Wachsmuth L, Kumari S, Schwarzer R, Lin J, Eren RO, et al. Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation. Nature. 2020;580:391\u20135.","journal-title":"Nature"},{"key":"490_CR51","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000495161","volume":"51","author":"H Tan","year":"2018","unstructured":"Tan H, Qi J, Fan BY, Zhang J, Su FF, Wang HT. MicroRNA-24-3p attenuates myocardial ischemia\/reperfusion injury by suppressing RIPK1 expression in mice. Cell Physiol Biochem. 2018;51:46\u201362.","journal-title":"Cell Physiol Biochem"},{"key":"490_CR52","doi-asserted-by":"crossref","first-page":"1451676","DOI":"10.1155\/2016\/1451676","volume":"2016","author":"M Zhao","year":"2016","unstructured":"Zhao M, Lu L, Lei S, Chai H, Wu S, Tang X, et al. Inhibition of receptor interacting protein kinases attenuates cardiomyocyte hypertrophy induced by palmitic acid. Oxid Med Cell Longev. 2016;2016:1451676.","journal-title":"Oxid Med Cell Longev"},{"key":"490_CR53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tibs.2018.11.002","volume":"44","author":"EJ Petrie","year":"2019","unstructured":"Petrie EJ, Czabotar PE, Murphy JM. The structural basis of necroptotic cell death signaling. Trends Biochem Sci. 2019;44:53\u201363.","journal-title":"Trends Biochem Sci"},{"key":"490_CR54","volume":"9","author":"H Guo","year":"2018","unstructured":"Guo H, Gilley RP, Fisher A, Lane R, Landsteiner VJ, Ragan KB, et al. Species-independent contribution of ZBP1\/DAI\/DLM-1-triggered necroptosis in host defense against HSV1. Cell Death Dis. 2018;9:816.","journal-title":"Cell Death Dis"},{"key":"490_CR55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12975-017-0581-z","volume":"9","author":"J Tian","year":"2018","unstructured":"Tian J, Guo S, Chen H, Peng JJ, Jia MM, Li NS, et al. Combination of emricasan with ponatinib synergistically reduces ischemia\/reperfusion injury in rat brain through simultaneous prevention of apoptosis and necroptosis. Transl Stroke Res. 2018;9:382\u201392.","journal-title":"Transl Stroke Res"},{"key":"490_CR56","doi-asserted-by":"publisher","unstructured":"Zheng XL, Yang JJ, Wang YY, Li Q, Song YP, Su M, et al. RIP1 promotes proliferation through G2\/M checkpoint progression and mediates cisplatin-induced apoptosis and necroptosis in human ovarian cancer cells. Acta Pharmacol Sin. 2020. https:\/\/doi.org\/10.1038\/s41401-019-0340-7.\u00a0Online ahead of print.","DOI":"10.1038\/s41401-019-0340-7"},{"key":"490_CR57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.4017","volume":"22","author":"T Zhang","year":"2016","unstructured":"Zhang T, Zhang Y, Cui M, Jin L, Wang Y, Lv F, et al. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat Med. 2016;22:175\u201382.","journal-title":"Nat Med"},{"key":"490_CR58","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1146\/annurev-biochem-060815-014830","volume":"85","author":"K Newton","year":"2016","unstructured":"Newton K, Manning G. Necroptosis and inflammation. Annu Rev Biochem. 2016;85:743\u201363.","journal-title":"Annu Rev Biochem"},{"key":"490_CR59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrm.2016.149","volume":"18","author":"R Weinlich","year":"2017","unstructured":"Weinlich R, Oberst A, Beere HM, Green DR. Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol. 2017;18:127\u201336.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"490_CR60","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fimmu.2019.00276","volume":"10","author":"Y Zhen","year":"2019","unstructured":"Zhen Y, Zhang H. NLRP3 inflammasome and inflammatory bowel disease. Front Immunol. 2019;10:276.","journal-title":"Front Immunol"},{"key":"490_CR61","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1016\/j.jid.2019.05.017","volume":"139","author":"AM Boniakowski","year":"2019","unstructured":"Boniakowski AM, denDekker AD, Davis FM, Joshi A, Kimball AS, Schaller M, et al. SIRT3 regulates macrophage-mediated inflammation in diabetic wound repair. J Investig Dermatol. 2019;139:2528\u201337.","journal-title":"J Investig Dermatol"},{"key":"490_CR62","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1080\/15548627.2019.1582743","volume":"15","author":"TS Kim","year":"2019","unstructured":"Kim TS, Jin YB, Kim YS, Kim S, Kim JK, Lee HM, et al. SIRT3 promotes antimycobacterial defenses by coordinating mitochondrial and autophagic functions. Autophagy. 2019;15:1356\u201375.","journal-title":"Autophagy"},{"key":"490_CR63","doi-asserted-by":"crossref","first-page":"e120722","DOI":"10.1172\/jci.insight.120722","volume":"4","author":"D Kurundkar","year":"2019","unstructured":"Kurundkar D, Kurundkar AR, Bone NB, Becker EJ Jr, Liu W, Chacko B, et al. SIRT3 diminishes inflammation and mitigates endotoxin-induced acute lung injury. JCI Insight. 2019;4:e120722.","journal-title":"JCI Insight"},{"key":"490_CR64","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fcvm.2020.00012","volume":"7","author":"N Kaludercic","year":"2020","unstructured":"Kaludercic N, Di Lisa F. Mitochondrial ROS formation in the pathogenesis of diabetic cardiomyopathy. Front Cardiovasc Med. 2020;7:12.","journal-title":"Front Cardiovasc Med"},{"key":"490_CR65","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1159\/000489241","volume":"46","author":"MY Wu","year":"2018","unstructured":"Wu MY, Yiang GT, Liao WT, Tsai AP, Cheng YL, Cheng PW, et al. Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 2018;46:1650\u201367.","journal-title":"Cell Physiol Biochem"},{"key":"490_CR66","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7555\/JBR.31.20160116","volume":"32","author":"ZM Zha","year":"2018","unstructured":"Zha ZM, Wang JH, Li SL, Guo Y. Pitavastatin attenuates AGEs-induced mitophagy via inhibition of ROS generation in the mitochondria of cardiomyocytes. J Biomed Res. 2018;32:281\u20137.","journal-title":"J Biomed Res"},{"key":"490_CR67","doi-asserted-by":"publisher","unstructured":"Chelladurai P, Boucherat O, Stenmark K, Kracht M, Seeger W, Bauer UM, et al. Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy. Br J Pharmacol. 2019. https:\/\/doi.org\/10.1111\/bph.14932.\u00a0Online ahead of print.","DOI":"10.1111\/bph.14932"},{"key":"490_CR68","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3389\/fphar.2018.01204","volume":"9","author":"J Zhang","year":"2018","unstructured":"Zhang J, Chen Y, Luo H, Sun L, Xu M, Yu J, et al. Recent update on the pharmacological effects and mechanisms of dihydromyricetin. Front Pharm. 2018;9:1204.","journal-title":"Front Pharm"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-0490-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-0490-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-0490-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T09:15:20Z","timestamp":1723367720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-0490-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["490"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-0490-7","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,7]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}